Negative regulation of leukocyte proliferation

pathway activity — cross-omics
GO:0070664Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of leukocyte proliferation pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are LAPTM5, MYO1F, and HCLS1, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of leukocyte proliferation activity versus LAPTM5 in OV (Pearson r = 0.44).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVLAPTM5 →+1.133+0.600.004.00437
GBMMYO1F →+0.736+1.002<.001<.00137
OVHCLS1 →+1.026+0.720<.001<.00137
GBMFPR1 →+1.119+1.094<.001<.00137
LSCCLYN →+0.621+0.705<.001.00137
GBMCD163 →+1.215+1.168<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0070664 vs LAPTM5 — OV

Per-sample scatter of Negative regulation of leukocyte proliferation activity vs LAPTM5 in OV.

Explore this scatter interactively →

Exploration